Digest Network Come funziona
Network
/
Società
Pu
Non verificato

PureTech Health plc

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

61 comunicati stampa

Guarda tutti i comunicati
10/06/2026
Biotecnologia
Salute
Scienza
Farmaceutica
PureTech Health: Results of Annual General Meeting
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
09/06/2026
Industria
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
13/05/2026
Industria
Salute
Farmaceutica
PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
29/04/2026
Mercato azionario
Web e Social Network
Telefonia e Varie
Tecnica
Medicina - Varie
Software
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
PureTech Announces Annual Results for Year Ended December 31, 2025
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
29/04/2026
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
27/04/2026
Mercato del lavoro
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
22/04/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
13/04/2026
Mercato azionario
Finanza
Web e Social Network
Telefonia e Varie
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
PureTech Health: Notice of Results
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
02/04/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Sanità
PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0
02/04/2026
Industria
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
Fonte
PureTech Health plc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0